Market News AIOpen the app

Tactile Systems Tech shared its Q3 2026 results, showing $91.9 million in sales and a 13% growth in lymphedema.

ResultsRead the original at Benzinga
Good for TCMD

Tactile Systems reported $91.9 million in Q3 sales, with lymphedema sales up 13%, and raised its adjusted profit forecast. Airway-clearance sales fell and are expected to decline for the year, but strength in its main business and the higher profit forecast make the report favorable.

TCMD · Tactile Systems Technology

AI read · Good for TCMD

The AI's read

The stronger profit forecast reflects the strength of Tactile's main lymphedema business. That business has grown by double digits for 5 straight quarters, and the share of sales left after product costs has grown for 12 straight quarters. Airway-clearance sales fell as distributors worked through excess inventory. Tactile expects that business to decline for the full year, but expects it to improve in Q4. The strong lymphedema business and higher profit forecast make the report favorable overall.

Get alerts for TCMD

Follow Tactile Systems Technology (TCMD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TCMD
Free on the App Store and Google Play, or on the web.